CN102238962B - 抗膜铁转运蛋白1单克隆抗体及其用途 - Google Patents
抗膜铁转运蛋白1单克隆抗体及其用途 Download PDFInfo
- Publication number
- CN102238962B CN102238962B CN200980148354.8A CN200980148354A CN102238962B CN 102238962 B CN102238962 B CN 102238962B CN 200980148354 A CN200980148354 A CN 200980148354A CN 102238962 B CN102238962 B CN 102238962B
- Authority
- CN
- China
- Prior art keywords
- seq
- fpn1
- human
- aminoacid sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12007608P | 2008-12-05 | 2008-12-05 | |
| US61/120,076 | 2008-12-05 | ||
| US23981809P | 2009-09-04 | 2009-09-04 | |
| US61/239,818 | 2009-09-04 | ||
| PCT/US2009/066187 WO2010065496A1 (en) | 2008-12-05 | 2009-12-01 | Anti-ferroportin 1 monoclonal antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102238962A CN102238962A (zh) | 2011-11-09 |
| CN102238962B true CN102238962B (zh) | 2014-02-12 |
Family
ID=41683589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200980148354.8A Expired - Fee Related CN102238962B (zh) | 2008-12-05 | 2009-12-01 | 抗膜铁转运蛋白1单克隆抗体及其用途 |
Country Status (25)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014027905A2 (pt) * | 2012-05-14 | 2017-06-27 | Genentech Inc | anticorpo, célula, ácido nucleico, métodos de identificação de um primeiro anticorpo, de inibição do crescimento de uma célula, de tratamento terapêutico, de determinação da presença de uma proteína, de diagnóstico da presença de um tumor e de distribuição de agente citotóxico. |
| WO2019213016A1 (en) | 2018-04-30 | 2019-11-07 | The Children's Hospital Of Philadelphia | Methods of improving anemias by combining agents |
| CA3156007A1 (en) | 2019-09-27 | 2021-04-01 | Disc Medicine, Inc. | METHODS OF TREATING MYELOFIBROSE AND ASSOCIATED CONDITIONS |
| CN110806486B (zh) * | 2019-11-23 | 2023-03-21 | 中南大学湘雅三医院 | Mafg/as1/pcbp2/fpn1调控轴作为靶位点检测试剂的应用 |
| AU2021273014A1 (en) | 2020-05-13 | 2022-11-17 | AbbVie Deutschland GmbH & Co. KG | Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease |
| ES3075793T3 (en) | 2020-05-13 | 2026-08-07 | Disc Medicine Inc | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| CN113980987A (zh) * | 2021-12-06 | 2022-01-28 | 上海市农业科学院 | 一种提高植物抗镍性能的PgIREG1S和AlATP-PRTS双基因组及其应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7166448B1 (en) * | 1999-05-10 | 2007-01-23 | Children's Medical Center Corproation | Ferroportin1 nucleic acids and proteins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319221B1 (it) * | 2000-10-17 | 2003-09-26 | Antonello Pietrangelo | Mutazioni nel gene della ferroportina 1 associata ad emocromatosiereditaria. |
| EP2803675A3 (en) * | 2008-01-25 | 2014-12-24 | Amgen, Inc | Ferroportin antibodies and methods of use |
-
2009
- 2009-11-23 PA PA20098849601A patent/PA8849601A1/es unknown
- 2009-11-24 AR ARP090104529A patent/AR074398A1/es unknown
- 2009-11-25 TW TW098140185A patent/TW201023891A/zh unknown
- 2009-12-01 DK DK09760073.8T patent/DK2373335T3/en active
- 2009-12-01 EA EA201170764A patent/EA020472B1/ru not_active IP Right Cessation
- 2009-12-01 MX MX2011005939A patent/MX2011005939A/es active IP Right Grant
- 2009-12-01 ES ES09760073.8T patent/ES2566343T3/es active Active
- 2009-12-01 UA UAA201107028A patent/UA104741C2/uk unknown
- 2009-12-01 KR KR1020117014053A patent/KR101353117B1/ko not_active Expired - Fee Related
- 2009-12-01 JP JP2011539625A patent/JP5713917B2/ja not_active Expired - Fee Related
- 2009-12-01 BR BRPI0922288A patent/BRPI0922288A2/pt not_active IP Right Cessation
- 2009-12-01 SG SG2011040797A patent/SG171960A1/en unknown
- 2009-12-01 NZ NZ592545A patent/NZ592545A/xx not_active IP Right Cessation
- 2009-12-01 AU AU2009322587A patent/AU2009322587B2/en not_active Ceased
- 2009-12-01 EP EP09760073.8A patent/EP2373335B1/en active Active
- 2009-12-01 SI SI200931382T patent/SI2373335T1/sl unknown
- 2009-12-01 PL PL09760073T patent/PL2373335T3/pl unknown
- 2009-12-01 CN CN200980148354.8A patent/CN102238962B/zh not_active Expired - Fee Related
- 2009-12-01 WO PCT/US2009/066187 patent/WO2010065496A1/en not_active Ceased
- 2009-12-01 HR HRP20160302TT patent/HRP20160302T1/hr unknown
- 2009-12-01 CA CA2745618A patent/CA2745618C/en not_active Expired - Fee Related
- 2009-12-01 HU HUE09760073A patent/HUE028585T2/en unknown
-
2011
- 2011-05-05 IL IL212731A patent/IL212731A0/en unknown
- 2011-05-27 ZA ZA2011/03941A patent/ZA201103941B/en unknown
-
2016
- 2016-04-12 CY CY20161100296T patent/CY1117355T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7166448B1 (en) * | 1999-05-10 | 2007-01-23 | Children's Medical Center Corproation | Ferroportin1 nucleic acids and proteins |
Non-Patent Citations (2)
| Title |
|---|
| Iron uptake and metabolism in the new millennium;Louise L. Dunn,et al;《TRENDS in Cell Biology》;20061227;第17卷(第2期);93-100 * |
| Regulation of Iron metabolism;Elizabeta Nemeth and Tomas Ganz;《Annu. Rev. Nutr》;20061231;第26卷(第2期);323-342 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010065496A1 (en) | 2010-06-10 |
| AR074398A1 (es) | 2011-01-12 |
| JP2012510814A (ja) | 2012-05-17 |
| CA2745618C (en) | 2014-06-10 |
| JP5713917B2 (ja) | 2015-05-07 |
| CA2745618A1 (en) | 2010-06-10 |
| AU2009322587A1 (en) | 2011-07-28 |
| EA201170764A1 (ru) | 2011-12-30 |
| HUE028585T2 (en) | 2016-12-28 |
| HK1158977A1 (zh) | 2012-07-27 |
| KR20110084996A (ko) | 2011-07-26 |
| UA104741C2 (uk) | 2014-03-11 |
| AU2009322587B2 (en) | 2013-09-26 |
| CN102238962A (zh) | 2011-11-09 |
| SG171960A1 (en) | 2011-07-28 |
| KR101353117B1 (ko) | 2014-02-17 |
| EP2373335A1 (en) | 2011-10-12 |
| MX2011005939A (es) | 2011-06-27 |
| IL212731A0 (en) | 2011-07-31 |
| TW201023891A (en) | 2010-07-01 |
| PL2373335T3 (pl) | 2016-08-31 |
| SI2373335T1 (sl) | 2016-04-29 |
| HRP20160302T1 (hr) | 2016-04-22 |
| NZ592545A (en) | 2012-12-21 |
| EA020472B1 (ru) | 2014-11-28 |
| ES2566343T3 (es) | 2016-04-12 |
| BRPI0922288A2 (pt) | 2018-08-28 |
| DK2373335T3 (en) | 2016-05-02 |
| ZA201103941B (en) | 2012-11-28 |
| PA8849601A1 (es) | 2010-07-27 |
| EP2373335B1 (en) | 2016-02-24 |
| CY1117355T1 (el) | 2017-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8679497B2 (en) | Anti-ferroportin 1 monoclonal antibodies and uses thereof | |
| AU2010286518B2 (en) | Therapeutic DLL4 binding proteins | |
| CN104936981B (zh) | Il‑17a结合物及其用途 | |
| EP3087097B1 (en) | Multifunctional antibodies binding to egfr and met | |
| AU2019201141B2 (en) | Novel antibody binding to TFPI and composition comprising the same | |
| CN113164766A (zh) | RGMc选择性抑制剂及其用途 | |
| CN105111308A (zh) | 抗N3pGlu淀粉样蛋白BETA肽抗体及其用途 | |
| TW201525004A (zh) | 結合前蛋白轉化酶枯草桿菌蛋白酶加工酶9型之人類抗原結合蛋白 | |
| KR20180044441A (ko) | 치료학적 dll4 결합 단백질 | |
| JP2023537422A (ja) | Il-11の抗体及びその使用 | |
| CN108473568A (zh) | 对TNF-α、IL-17A和IL-17F具有特异性的多特异性抗体分子 | |
| KR20190021244A (ko) | 항-axl 길항성 항체 | |
| JP5713917B2 (ja) | 抗フェロポーチン1モノクローナル抗体およびその使用 | |
| KR20250153216A (ko) | Fap/cd40 결합 분자의 약학적 조성물 및 이의 의약적 용도 | |
| KR20220007128A (ko) | 항-sema3a 항체 및 눈 또는 안구 질환 치료를 위한 이의 용도 | |
| US20260098096A1 (en) | Anti-ccr8 antibodies | |
| CA3205846A1 (en) | Anti-pdgf-b antibodies and mehods of use for treating pulmonary arterial hypertension (pah) | |
| JPWO2019054460A1 (ja) | 抗ramp2抗体 | |
| HK1158977B (en) | Anti-ferroportin 1 monoclonal antibodies and uses thereof | |
| WO2025113639A1 (zh) | 抗gdf15的抗体及其方法和用途 | |
| CN120437287A (zh) | 一种包含特异性结合gucy2c和cd3的双特异性抗体的药物组合物 | |
| WO2025152915A1 (zh) | 抗肾上腺髓质素抗体在预防或治疗脑卒中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140212 Termination date: 20171201 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |